tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ResMed price target raised to $314 from $311 at RBC Capital
The FlyResMed price target raised to $314 from $311 at RBC Capital
2d ago
RMD
ResMed price target raised to $302 from $299 at KeyBanc
PremiumThe Fly
ResMed price target raised to $302 from $299 at KeyBanc
2d ago
RMD
ResMed price target raised to $265 from $260 at Stifel
PremiumThe Fly
ResMed price target raised to $265 from $260 at Stifel
2d ago
RMD
ResMed price target raised to $281 from $275 at Baird
PremiumThe Fly
ResMed price target raised to $281 from $275 at Baird
2d ago
RMD
ResMed price target raised to $275 from $270 at Piper Sandler
PremiumThe Fly
ResMed price target raised to $275 from $270 at Piper Sandler
2d ago
RMD
ResMed reports Q2 EPS $2.81, consensus $2.72
PremiumThe FlyResMed reports Q2 EPS $2.81, consensus $2.72
2d ago
RMD
RMD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
RMD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5d ago
ResMed CEO Michael Farrell Exercises Options and Sells Shares Under 10b5-1 Plan
Premium
Company Announcements
ResMed CEO Michael Farrell Exercises Options and Sells Shares Under 10b5-1 Plan
18d ago
ResMed Chairman Emeritus Peter Farrell Sells 2,000 Shares Under Trading Plan
PremiumCompany Announcements
ResMed Chairman Emeritus Peter Farrell Sells 2,000 Shares Under Trading Plan
18d ago
Resmed Sets January 29 Date to Unveil Q2 FY2026 Results
PremiumCompany Announcements
Resmed Sets January 29 Date to Unveil Q2 FY2026 Results
23d ago
ResMed CEO Michael Farrell Plans Further Insider Share Sale Under Rule 144
PremiumCompany Announcements
ResMed CEO Michael Farrell Plans Further Insider Share Sale Under Rule 144
23d ago
ResMed Director Peter Farrell Plans Additional Insider Share Sale Under Rule 144
PremiumCompany Announcements
ResMed Director Peter Farrell Plans Additional Insider Share Sale Under Rule 144
24d ago
ResMed General Counsel Discloses Small Share Sale Under 10b5-1 Trading Plan
PremiumCompany AnnouncementsResMed General Counsel Discloses Small Share Sale Under 10b5-1 Trading Plan
24d ago
ResMed CFO Sells Small Block of Shares Under Pre-Arranged Trading Plan
Premium
Company Announcements
ResMed CFO Sells Small Block of Shares Under Pre-Arranged Trading Plan
24d ago
ResMed Updates CDI and Share Structure for December 2025
Premium
Company Announcements
ResMed Updates CDI and Share Structure for December 2025
26d ago
ResMed Officer Brett Sandercock Discloses Planned Sale of 1,000 Shares Under Trading Plan
PremiumCompany Announcements
ResMed Officer Brett Sandercock Discloses Planned Sale of 1,000 Shares Under Trading Plan
26d ago
ResMed Executive Files Routine Rule 144 Notice for Small Share Sale
PremiumCompany Announcements
ResMed Executive Files Routine Rule 144 Notice for Small Share Sale
26d ago
ResMed price target lowered to $260 from $270 at Stifel
PremiumThe Fly
ResMed price target lowered to $260 from $270 at Stifel
1M ago
RMD
ResMed downgraded to Neutral from Outperform at Baird
PremiumThe Fly
ResMed downgraded to Neutral from Outperform at Baird
2M ago
RMD
ResMed CEO Reports Strategic Stock Transactions
PremiumCompany AnnouncementsResMed CEO Reports Strategic Stock Transactions
2M ago
ResMed receives FDA clearance for PTCS to be marketed as Smart Comfort
Premium
The Fly
ResMed receives FDA clearance for PTCS to be marketed as Smart Comfort
2M ago
RMD
ResMed Inc Announces Changes in Beneficial Ownership
Premium
Company Announcements
ResMed Inc Announces Changes in Beneficial Ownership
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >